99 results
Page 5 of 5
8-K
EX-10.1
vud zurenb
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.7
yhrklm
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-99.1
ynsshfxlcevr2l6
14 Aug 18
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
l7daq9 oaipsan5
25 May 18
Regulation FD Disclosure
8:30am
8-K
EX-99.1
usc jhpjwuqg38yh0js
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
8-K
EX-99.1
znf1az
3 May 18
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am
DEF 14A
zlvb3w 6x66sf4p32bs
30 Apr 18
Definitive proxy
7:02am
10-K
nln lb16d8w9byzva
1 Mar 18
Annual report
12:00am
8-K
EX-99.1
pmtjrrcvlerzhhha8o2
14 Jul 17
Other Events
12:00am
10-Q
0mu0z
12 May 17
Quarterly report
12:00am
10-12G/A
szo lufz4bf1d
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
nn17u5dk6n 8l
6 Mar 17
Registration of securities (amended)
12:00am
10-12G
i5ghqxhpum9zr1w
12 Jan 17
Registration of securities
12:00am
10-12G/A
jtf fcygd2ug5vzhli
18 Feb 16
Registration of securities (amended)
12:00am
10-12G
pvdg p68wbwg0a9xfk
30 Dec 15
Registration of securities
12:00am